Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sudeep Pharma Limited ( (IN:SUDEEPPHRM) ) has issued an announcement.
Sudeep Pharma Limited has submitted to the stock exchanges the transcript of its Q2 FY26 earnings conference call, which discussed the company’s standalone and consolidated unaudited financial and operational performance for the quarter and half year ended 30 September 2025. The transcript, edited for factual accuracy and readability, complements the previously shared audio recording of the 22 December 2025 earnings call and has been made available on the company’s website, enhancing transparency and access to information for analysts and investors.
More about Sudeep Pharma Limited
Sudeep Pharma Limited operates in the pharmaceutical and specialty chemicals industry, focusing on manufacturing and supplying pharma-related products and ingredients. The company serves domestic and international markets from its facilities and offices in Gujarat, India, and is listed on both the National Stock Exchange of India and BSE under the symbols SUDEEPPHRM and 544619, respectively.
Average Trading Volume: 437,083
For an in-depth examination of SUDEEPPHRM stock, go to TipRanks’ Overview page.